Related Experiment Video
Updated: Feb 23, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Phelan-McDermid syndrome data network: Integrating patient reported outcomes with clinical notes and curated genetic
Cartik Kothari1, Maxime Wack1, Claire Hassen-Khodja1
1Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
Abstract:
The heterogeneity of patient phenotype data are an impediment to the research into the origins and progression of neuropsychiatric disorders. This difficulty is compounded in the case of rare disorders such as Phelan-McDermid Syndrome (PMS) by the paucity of patient clinical data. PMS is a rare syndromic genetic cause of autism and intellectual deficiency. In this paper, we describe the Phelan-McDermid Syndrome Data Network (PMS_DN), a platform that facilitates research into phenotype-genotype correlation and progression of PMS by: a) integrating knowledge of patient phenotypes extracted from Patient Reported Outcomes (PRO) data and clinical notes-two heterogeneous, underutilized sources of knowledge about patient phenotypes-with curated genetic information from the same patient cohort and b) making this integrated knowledge, along with a suite of statistical tools, available free of charge to authorized investigators on a Web portal https://pmsdn.hms.harvard.edu. PMS_DN is a Patient Centric Outcomes Research Initiative (PCORI) where patients and their families are involved in all aspects of the management of patient data in driving research into PMS. To foster collaborative research, PMS_DN also makes patient aggregates from this knowledge available to authorized investigators using distributed research networks such as the PCORnet PopMedNet. PMS_DN is hosted on a scalable cloud based environment and complies with all patient data privacy regulations. As of October 31, 2016, PMS_DN integrates high-quality knowledge extracted from the clinical notes of 112 patients and curated genetic reports of 176 patients with preprocessed PRO data from 415 patients.
Insights
The Phelan-McDermid Syndrome Data Network (PMS_DN) integrates diverse patient data to advance research into this rare genetic disorder. This platform aids in understanding phenotype-genotype correlations and disease progression for improved patient outcomes.
Area of Science:
- Neuroscience
- Genetics
- Bioinformatics
Background:
- Heterogeneous patient data hinders neuropsychiatric disorder research, especially for rare conditions like Phelan-McDermid Syndrome (PMS).
- Paucity of clinical data for rare disorders like PMS complicates understanding disease origins and progression.
- Phelan-McDermid Syndrome is a rare genetic disorder associated with autism and intellectual disability.
Purpose of the Study:
- To describe the Phelan-McDermid Syndrome Data Network (PMS_DN), a platform designed to facilitate research into PMS.
- To integrate heterogeneous patient phenotype data (PROs, clinical notes) with genetic information for PMS research.
- To provide authorized investigators with access to integrated PMS data and statistical tools for phenotype-genotype correlation and progression studies.
Main Methods:
- Integrating patient-reported outcomes (PRO) and clinical notes with curated genetic data.
- Developing a web portal (https://pmsdn.hms.harvard.edu) for authorized investigator access.
- Utilizing distributed research networks like PCORnet PopMedNet for aggregate data sharing.
Main Results:
- As of October 31, 2016, PMS_DN integrated data from 112 patients' clinical notes, 176 patients' genetic reports, and 415 patients' PRO data.
- The platform facilitates research into phenotype-genotype correlation and disease progression in PMS.
- PMS_DN is hosted on a scalable cloud environment, adhering to privacy regulations.
Conclusions:
- The PMS_DN platform effectively integrates diverse patient data to overcome research challenges in rare disorders like PMS.
- The initiative empowers patients and families in data management and research direction.
- PMS_DN fosters collaborative research by providing access to integrated data and promoting data sharing through networks.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genomics

